PT75643B - Method for preparing dna,recombinant dna hosts containing them and polipeptides - Google Patents

Method for preparing dna,recombinant dna hosts containing them and polipeptides

Info

Publication number
PT75643B
PT75643B PT75643A PT7564382A PT75643B PT 75643 B PT75643 B PT 75643B PT 75643 A PT75643 A PT 75643A PT 7564382 A PT7564382 A PT 7564382A PT 75643 B PT75643 B PT 75643B
Authority
PT
Portugal
Prior art keywords
dna
polipeptides
hosts containing
preparing
recombinant dna
Prior art date
Application number
PT75643A
Other languages
English (en)
Other versions
PT75643A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT75643(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT75643A publication Critical patent/PT75643A/pt
Publication of PT75643B publication Critical patent/PT75643B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT75643A 1981-10-03 1982-10-01 Method for preparing dna,recombinant dna hosts containing them and polipeptides PT75643B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8208988 1982-03-26
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (2)

Publication Number Publication Date
PT75643A PT75643A (en) 1982-11-01
PT75643B true PT75643B (en) 1986-11-13

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75643A PT75643B (en) 1981-10-03 1982-10-01 Method for preparing dna,recombinant dna hosts containing them and polipeptides

Country Status (19)

Country Link
US (1) US5089400A (pt)
EP (1) EP0076489B1 (pt)
JP (2) JPH06104066B2 (pt)
KR (1) KR920007665B1 (pt)
AU (1) AU561104B2 (pt)
DD (1) DD204266A5 (pt)
DE (1) DE3280174D1 (pt)
DK (1) DK170714B1 (pt)
ES (2) ES516154A0 (pt)
FI (1) FI80719C (pt)
GB (1) GB2108510B (pt)
GR (1) GR76992B (pt)
HU (1) HU197047B (pt)
IE (1) IE54051B1 (pt)
IL (1) IL66920A0 (pt)
NO (1) NO166494C (pt)
NZ (1) NZ202058A (pt)
PH (2) PH21524A (pt)
PT (1) PT75643B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
JPS59501866A (ja) * 1982-10-11 1984-11-08 ナショナル・リサ−チ・ディベロップメント・コ−ポレイション 腸内ウイルスに対するワクチン接種に有用なポリペプチド
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0194006B1 (en) * 1985-02-01 1992-04-29 Imperial Chemical Industries Plc Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
ATE81675T1 (de) * 1985-04-30 1992-11-15 Takeda Chemical Industries Ltd Produktion eines proteins.
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
EP0242329B1 (en) 1986-04-15 1995-07-19 Ciba-Geigy Ag Monoclonal antibodies against interferon-induced human protein in pure form, and test kits containing these antibodies
TW218846B (pt) * 1992-04-07 1994-01-11 Ciba Geigy
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5834202A (en) * 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
ATE207538T1 (de) 1995-02-09 2001-11-15 Behringwerke Ag Verfahren zur produktion von proteinen
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
IL155741A0 (en) 2000-11-03 2003-12-23 Pbl Biomedical Lab Interferons, uses and compositions related thereto
WO2002088161A1 (en) * 2001-05-02 2002-11-07 Pepgen Corporation Method for expression of human interferon alpha 1 in pichia pa storis
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
AU2005317574B2 (en) * 2004-12-20 2011-11-03 Cadila Healthcare Limited Process for preparing high levels of interferon beta
KR102036463B1 (ko) 2016-11-21 2019-10-24 닛토덴코 가부시키가이샤 점착 시트
KR102055078B1 (ko) 2016-11-21 2019-12-11 닛토덴코 가부시키가이샤 점착 시트

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
DK170236B1 (da) * 1980-01-08 1995-07-10 Biogen Inc Rekombinante DNA-molekyler, fremgangsmåde til fremstilling af et polypeptid af IFN-alfa typen og fremgangsmåde til udvælgelse af DNA-sekvenser, der koder for polypeptider af IFN-alfa typen
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
JP2687995B2 (ja) * 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
EP0076489A2 (de) 1983-04-13
NO823314L (no) 1983-04-05
PH21524A (en) 1987-11-16
FI80719C (fi) 1990-07-10
JPH07173195A (ja) 1995-07-11
AU8895882A (en) 1983-04-14
FI823356A0 (fi) 1982-10-01
KR840002031A (ko) 1984-06-11
DD204266A5 (de) 1983-11-23
ES528141A0 (es) 1985-11-01
AU561104B2 (en) 1987-04-30
DK437382A (da) 1983-04-04
JPS5890596A (ja) 1983-05-30
ES8601237A1 (es) 1985-11-01
GB2108510B (en) 1984-12-12
KR920007665B1 (ko) 1992-09-14
US5089400A (en) 1992-02-18
ES8504936A1 (es) 1985-04-16
FI80719B (fi) 1990-03-30
NZ202058A (en) 1986-05-09
ES516154A0 (es) 1985-04-16
PT75643A (en) 1982-11-01
IL66920A0 (en) 1982-12-31
NO166494B (no) 1991-04-22
JPH06104066B2 (ja) 1994-12-21
DE3280174D1 (de) 1990-06-21
DK170714B1 (da) 1995-12-18
IE822385L (en) 1983-04-30
EP0076489A3 (en) 1984-03-28
FI823356L (fi) 1983-04-04
GB2108510A (en) 1983-05-18
NO166494C (no) 1991-08-07
PH23119A (en) 1989-05-05
GR76992B (pt) 1984-09-04
JP2612149B2 (ja) 1997-05-21
HU197047B (en) 1989-02-28
EP0076489B1 (de) 1990-05-16
IE54051B1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
PT75643B (en) Method for preparing dna,recombinant dna hosts containing them and polipeptides
DE3177100D1 (en) Method for stabilizing and selecting host cells containing recombinant dna
IL67176A0 (en) Method for stabilizing and selecting recombinant dna containing host cells
EP0188388A3 (en) Alpha-alumina particles, and process for preparing the same
AU1274483A (en) Interferon dna
BG38487A3 (en) Method for preparing peptides
DE3364300D1 (en) Photobleach system, composition and process
GB2068971B (en) Recombinant dna techniques
DE3479322D1 (en) Dna sequence
DE3566888D1 (en) Silanes, process for their preparation and their use
DE3566890D1 (en) Perfluoralkylnorbornyl silanes or -siloxanes, process for preparing them and their use
HUT39362A (en) Process for preparing polypeptide vaccine
DE3264284D1 (en) Bisimidazolines, process for their preparation and their use
EP0174375A4 (en) PRODUCTION PROCESS FOR N-ACYLPHENYLALANINE.
JPS57202281A (en) Improved brewing method
ZA858446B (en) Antibiotic polypeptide,process for preparing it and the use thereof
DE3172076D1 (en) New peptide, process for preparation thereof and use thereof
AU545908B2 (en) Recombinant dna techniques
DE3263582D1 (en) Peptide, process for preparation thereof and use thereof
GB8412158D0 (en) Recombinant dna derived antigens
EP0146627A4 (en) NEW IMMUNOGLOBULIN CODING DNA.
EP0227833A4 (en) PROCESS FOR THE PREPARATION OF HETERO-PROTEIN.
DE3169145D1 (en) Peptide, process for preparation thereof and use thereof
ZA831045B (en) Photobleach system,composition and process
ZA8219B (en) Recombinant dna means and method

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 970612 NOVARTIS AG CH

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990531